CVSS: 5.3EPSS: 0%CPEs: 1EXPL: 0CVE-2020-15077
https://notcve.org/view.php?id=CVE-2020-15077
OpenVPN Access Server 2.8.7 and earlier versions allows a remote attackers to bypass authentication and access control channel data on servers configured with deferred authentication, which can be used to potentially trigger further information leaks. OpenVPN Access Server versiones 2.8.7 y anteriores, permiten a atacantes remotos omitir la autenticación y los datos del canal de control de acceso en servidores configurados con autenticación diferida, que puede ser usado para desencadenar potencialmente nuevos filtrados de información • https://openvpn.net/security-advisory/access-server-security-update-cve-2020-15077 https://openvpn.net/vpn-server-resources/release-notes • CWE-287: Improper Authentication CWE-305: Authentication Bypass by Primary Weakness •
CVSS: 7.5EPSS: 0%CPEs: 2EXPL: 0CVE-2020-15074
https://notcve.org/view.php?id=CVE-2020-15074
OpenVPN Access Server older than version 2.8.4 and version 2.9.5 generates new user authentication tokens instead of reusing exiting tokens on reconnect making it possible to circumvent the initial token expiry timestamp. El servidor de acceso OpenVPN anterior a la versión 2.8.4 y la versión 2.9.5 genera nuevos tokens de autenticación de usuario en lugar de reutilizar los tokens existentes en la reconexión, lo que permite eludir la marca de tiempo de caducidad del token inicial • https://openvpn.net/vpn-server-resources/release-notes • CWE-302: Authentication Bypass by Assumed-Immutable Data CWE-613: Insufficient Session Expiration •
CVSS: 7.5EPSS: 0%CPEs: 2EXPL: 0CVE-2020-11462
https://notcve.org/view.php?id=CVE-2020-11462
An issue was discovered in OpenVPN Access Server before 2.7.0 and 2.8.x before 2.8.3. With the full featured RPC2 interface enabled, it is possible to achieve a temporary DoS state of the management interface when sending an XML Entity Expansion (XEE) payload to the XMLRPC based RPC2 interface. The duration of the DoS state depends on available memory and CPU speed. The default restricted mode of the RPC2 interface is NOT vulnerable. Se ha descubierto un problema en OpenVPN Access Server versiones anteriores a la versión 2.7.0 y versiones 2.8.x anteriores a la versión 2.8.3. • https://openvpn.net/vpn-server-resources/release-notes/#Release_notes_for_OpenVPN_Access_Server_283 • CWE-776: Improper Restriction of Recursive Entity References in DTDs ('XML Entity Expansion') •
CVSS: 9.8EPSS: 0%CPEs: 1EXPL: 0CVE-2020-8953
https://notcve.org/view.php?id=CVE-2020-8953
OpenVPN Access Server 2.8.x before 2.8.1 allows LDAP authentication bypass (except when a user is enrolled in two-factor authentication). OpenVPN Access Server versiones 2.8.x anteriores a 2.8.1, permite una omisión de autenticación LDAP (excepto cuando un usuario está inscrito en autenticación de dos factores). • https://openvpn.net/security-advisories • CWE-287: Improper Authentication •
CVSS: 6.1EPSS: 0%CPEs: 1EXPL: 2CVE-2017-5868 – OpenVPN Access Server 2.1.4 CRLF Injection
https://notcve.org/view.php?id=CVE-2017-5868
CRLF injection vulnerability in the web interface in OpenVPN Access Server 2.1.4 allows remote attackers to inject arbitrary HTTP headers and consequently conduct session fixation attacks and possibly HTTP response splitting attacks via "%0A" characters in the PATH_INFO to __session_start__/. Una vulnerabilidad de inyección CRLF en la interfaz web en OpenVPN Access Server versión 2.1.4, permite a los atacantes remotos inyectar encabezados HTTP arbitrarios y, en consecuencia, conducir ataques de fijación de sesión y posiblemente ataques de división de respuesta HTTP por medio de caracteres "%0A" en la variable PATH_INFO en la función __session_start __ /. OpenVPN Access Server version 2.1.4 suffers from a CRLF injection vulnerability. • http://www.openwall.com/lists/oss-security/2017/05/23/13 http://www.securitytracker.com/id/1038547 https://sysdream.com/news/lab/2017-05-05-cve-2017-5868-openvpn-access-server-crlf-injection-with-session-fixation • CWE-93: Improper Neutralization of CRLF Sequences ('CRLF Injection') •